High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane
Journal article published in 2020 by
Dinja T. Kruger,
Maurice P. H. M. Jansen 
,
Inge R. H. M. Konings,
Wouter M. Dercksen,
Agnes Jager,
Jamal Oulad Hadj,
Stefan Sleijfer,
John W. M. Martens,
Epie Boven
,
Inge R. H. M. Konings,
Wouter M. Dercksen,
Agnes Jager,
Jamal Oulad Hadj,
Stefan Sleijfer,
John W. M. Martens,
Epie Boven
This paper is made freely available by the publisher.
Full text: Download
Data provided by 